• Collaborating with other organizations by building coalitions of CV associations across various specialty organizations, including CV subspecialty organizations, and positioning research and GME among high-priority advocacy issues
• Projecting relative prevalence of various categories of life-threatening/debilitating CV diseases; predicting the direct and indirect costs and requirements for different specialties and subspecialties under various scenarios; projecting potential savings and cost-effectiveness based on incremental research investment, and the economic impact of maintaining or augmenting research and GME
• Educating doctors the general public by joining the educational efforts of the AMCC, developing appropriate education materials, and participating in educational endeavors in both “academic” and “practice “ communities
• Advocating for CV issues by seeking sufficient appropriations and regulatory direction that allows for the sustainment of AMCs and their missions; Encouraging approaches to incentivize AMCs to improve their internal and external structure to function within the evolving healthcare environment; Assuming accountability by the academic community to improve efficiency and relevance of GME & research efforts, as well as cost-effectiveness of clinical care